• レポートコード:D0804-15621 • 出版社/出版日:GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態:英語、PDF、107ページ • 納品方法:Eメール • 産業分類:医薬品・治療 |
Single User | ¥487,200 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥730,800 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、コンピュータ支援薬物の世界市場を広く調査・分析し、今後の市場展望をまとめております。コンピュータ支援薬物の種類別市場規模(構造物系薬物、リガンド系薬物)、用途別市場規模(腫瘍性疾患、神経疾患、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報(販売量、市場シェア、製品概要、SWOT分析):Market Positioning Of Vendors、International Business Machines Corp.、Charles River Laboratories International Inc.、Aaranya Biosciences Pvt. Ltd.、Compchem Solutions Ltd.、Albany Molecular Research Inc.、Openeye Scientific Software Inc.、Chemical Computing Group ULC、Chembio Discovery Inc.、Kang Yusheng Information Technology Co. Ltd.、Pharmaron Beijing Co. Ltd. ・地域別グローバル市場分析 2015年-2020年 ・コンピュータ支援薬物の北米市場(アメリカ、カナダ、メキシコ) ・コンピュータ支援薬物のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア) ・コンピュータ支援薬物のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア) ・コンピュータ支援薬物の南米市場(ブラジル、アルゼンチン) ・コンピュータ支援薬物の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ) ・種類別分析:構造物系薬物、リガンド系薬物 ・用途別分析:腫瘍性疾患、神経疾患、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Computer-Aided Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Computer-Aided Drug sales will be xx in 2020 from Computer-Aided Drug million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Computer-Aided Drug market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Computer-Aided Drug industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Computer-Aided Drug and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Computer-Aided Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Computer-Aided Drug market has been segmented into:
Structure Based Drug
Ligand Based Drug
By Application, Computer-Aided Drug has been segmented into:
Oncological Disorders
Neurological Disorders
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Computer-Aided Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Computer-Aided Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Computer-Aided Drug market.
The report offers in-depth assessment of the growth and other aspects of the Computer-Aided Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Computer-Aided Drug Market Share Analysis
Computer-Aided Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Computer-Aided Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Computer-Aided Drug sales, revenue and market share for each player covered in this report.
The major players covered in Computer-Aided Drug are:
Market Positioning Of Vendors
International Business Machines Corp.
Charles River Laboratories International Inc.
Aaranya Biosciences Pvt. Ltd.
Compchem Solutions Ltd.
Albany Molecular Research Inc.
Openeye Scientific Software Inc.
Chemical Computing Group ULC
Chembio Discovery Inc.
Kang Yusheng Information Technology Co. Ltd.
Pharmaron Beijing Co. Ltd.
1 Computer-Aided Drug Market Overview
1.1 Product Overview and Scope of Computer-Aided Drug
1.2 Classification of Computer-Aided Drug by Type
1.2.1 Global Computer-Aided Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Computer-Aided Drug Revenue Market Share by Type in 2019
1.2.3 Structure Based Drug
1.2.4 Ligand Based Drug
1.3 Global Computer-Aided Drug Market by Application
1.3.1 Overview: Global Computer-Aided Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Oncological Disorders
1.3.3 Neurological Disorders
1.3.4 Other
1.4 Global Computer-Aided Drug Market by Regions
1.4.1 Global Computer-Aided Drug Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Computer-Aided Drug (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Computer-Aided Drug Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Computer-Aided Drug Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Computer-Aided Drug Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Computer-Aided Drug Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Computer-Aided Drug Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Computer-Aided Drug Industry Impact
1.5.1 COVID-19 Potential Implications for the Computer-Aided Drug
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Computer-Aided Drug
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Market Positioning Of Vendors
2.1.1 Market Positioning Of Vendors Details
2.1.2 Market Positioning Of Vendors Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Market Positioning Of Vendors SWOT Analysis
2.1.4 Market Positioning Of Vendors Product and Services
2.1.5 Market Positioning Of Vendors Computer-Aided Drug Revenue, Gross Margin and Market Share (2018-2019)
2.2 International Business Machines Corp.
2.2.1 International Business Machines Corp. Details
2.2.2 International Business Machines Corp. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 International Business Machines Corp. SWOT Analysis
2.2.4 International Business Machines Corp. Product and Services
2.2.5 International Business Machines Corp. Computer-Aided Drug Revenue, Gross Margin and Market Share (2018-2019)
2.3 Charles River Laboratories International Inc.
2.3.1 Charles River Laboratories International Inc. Details
2.3.2 Charles River Laboratories International Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Charles River Laboratories International Inc. SWOT Analysis
2.3.4 Charles River Laboratories International Inc. Product and Services
2.3.5 Charles River Laboratories International Inc. Computer-Aided Drug Revenue, Gross Margin and Market Share (2018-2019)
2.4 Aaranya Biosciences Pvt. Ltd.
2.4.1 Aaranya Biosciences Pvt. Ltd. Details
2.4.2 Aaranya Biosciences Pvt. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Aaranya Biosciences Pvt. Ltd. SWOT Analysis
2.4.4 Aaranya Biosciences Pvt. Ltd. Product and Services
2.4.5 Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Revenue, Gross Margin and Market Share (2018-2019)
2.5 Compchem Solutions Ltd.
2.5.1 Compchem Solutions Ltd. Details
2.5.2 Compchem Solutions Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Compchem Solutions Ltd. SWOT Analysis
2.5.4 Compchem Solutions Ltd. Product and Services
2.5.5 Compchem Solutions Ltd. Computer-Aided Drug Revenue, Gross Margin and Market Share (2018-2019)
2.6 Albany Molecular Research Inc.
2.6.1 Albany Molecular Research Inc. Details
2.6.2 Albany Molecular Research Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Albany Molecular Research Inc. SWOT Analysis
2.6.4 Albany Molecular Research Inc. Product and Services
2.6.5 Albany Molecular Research Inc. Computer-Aided Drug Revenue, Gross Margin and Market Share (2018-2019)
2.7 Openeye Scientific Software Inc.
2.7.1 Openeye Scientific Software Inc. Details
2.7.2 Openeye Scientific Software Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Openeye Scientific Software Inc. SWOT Analysis
2.7.4 Openeye Scientific Software Inc. Product and Services
2.7.5 Openeye Scientific Software Inc. Computer-Aided Drug Revenue, Gross Margin and Market Share (2018-2019)
2.8 Chemical Computing Group ULC
2.8.1 Chemical Computing Group ULC Details
2.8.2 Chemical Computing Group ULC Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Chemical Computing Group ULC SWOT Analysis
2.8.4 Chemical Computing Group ULC Product and Services
2.8.5 Chemical Computing Group ULC Computer-Aided Drug Revenue, Gross Margin and Market Share (2018-2019)
2.9 Chembio Discovery Inc.
2.9.1 Chembio Discovery Inc. Details
2.9.2 Chembio Discovery Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Chembio Discovery Inc. SWOT Analysis
2.9.4 Chembio Discovery Inc. Product and Services
2.9.5 Chembio Discovery Inc. Computer-Aided Drug Revenue, Gross Margin and Market Share (2018-2019)
2.10 Kang Yusheng Information Technology Co. Ltd.
2.10.1 Kang Yusheng Information Technology Co. Ltd. Details
2.10.2 Kang Yusheng Information Technology Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Kang Yusheng Information Technology Co. Ltd. SWOT Analysis
2.10.4 Kang Yusheng Information Technology Co. Ltd. Product and Services
2.10.5 Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Revenue, Gross Margin and Market Share (2018-2019)
2.11 Pharmaron Beijing Co. Ltd.
2.11.1 Pharmaron Beijing Co. Ltd. Details
2.11.2 Pharmaron Beijing Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Pharmaron Beijing Co. Ltd. SWOT Analysis
2.11.4 Pharmaron Beijing Co. Ltd. Product and Services
2.11.5 Pharmaron Beijing Co. Ltd. Computer-Aided Drug Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Computer-Aided Drug Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Computer-Aided Drug Players Market Share
3.2.2 Top 10 Computer-Aided Drug Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Computer-Aided Drug Revenue and Market Share by Regions
4.2 North America Computer-Aided Drug Revenue and Growth Rate (2015-2020)
4.3 Europe Computer-Aided Drug Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Computer-Aided Drug Revenue and Growth Rate (2015-2020)
4.5 South America Computer-Aided Drug Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Computer-Aided Drug Revenue and Growth Rate (2015-2020)
5 North America Computer-Aided Drug Revenue by Countries
5.1 North America Computer-Aided Drug Revenue by Countries (2015-2020)
5.2 USA Computer-Aided Drug Revenue and Growth Rate (2015-2020)
5.3 Canada Computer-Aided Drug Revenue and Growth Rate (2015-2020)
5.4 Mexico Computer-Aided Drug Revenue and Growth Rate (2015-2020)
6 Europe Computer-Aided Drug Revenue by Countries
6.1 Europe Computer-Aided Drug Revenue by Countries (2015-2020)
6.2 Germany Computer-Aided Drug Revenue and Growth Rate (2015-2020)
6.3 UK Computer-Aided Drug Revenue and Growth Rate (2015-2020)
6.4 France Computer-Aided Drug Revenue and Growth Rate (2015-2020)
6.5 Russia Computer-Aided Drug Revenue and Growth Rate (2015-2020)
6.6 Italy Computer-Aided Drug Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Computer-Aided Drug Revenue by Countries
7.1 Asia-Pacific Computer-Aided Drug Revenue by Countries (2015-2020)
7.2 China Computer-Aided Drug Revenue and Growth Rate (2015-2020)
7.3 Japan Computer-Aided Drug Revenue and Growth Rate (2015-2020)
7.4 Korea Computer-Aided Drug Revenue and Growth Rate (2015-2020)
7.5 India Computer-Aided Drug Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Computer-Aided Drug Revenue and Growth Rate (2015-2020)
8 South America Computer-Aided Drug Revenue by Countries
8.1 South America Computer-Aided Drug Revenue by Countries (2015-2020)
8.2 Brazil Computer-Aided Drug Revenue and Growth Rate (2015-2020)
8.3 Argentina Computer-Aided Drug Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Computer-Aided Drug by Countries
9.1 Middle East & Africa Computer-Aided Drug Revenue by Countries (2015-2020)
9.2 Saudi Arabia Computer-Aided Drug Revenue and Growth Rate (2015-2020)
9.3 UAE Computer-Aided Drug Revenue and Growth Rate (2015-2020)
9.4 Egypt Computer-Aided Drug Revenue and Growth Rate (2015-2020)
9.5 South Africa Computer-Aided Drug Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Computer-Aided Drug Revenue and Market Share by Type (2015-2020)
10.2 Global Computer-Aided Drug Market Forecast by Type (2019-2024)
10.3 Structure Based Drug Revenue Growth Rate (2015-2025)
10.4 Ligand Based Drug Revenue Growth Rate (2015-2025)
11 Global Computer-Aided Drug Market Segment by Application
11.1 Global Computer-Aided Drug Revenue Market Share by Application (2015-2020)
11.2 Computer-Aided Drug Market Forecast by Application (2019-2024)
11.3 Oncological Disorders Revenue Growth (2015-2020)
11.4 Neurological Disorders Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Computer-Aided Drug Market Size Forecast (2021-2025)
12.1 Global Computer-Aided Drug Market Size Forecast (2021-2025)
12.2 Global Computer-Aided Drug Market Forecast by Regions (2021-2025)
12.3 North America Computer-Aided Drug Revenue Market Forecast (2021-2025)
12.4 Europe Computer-Aided Drug Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Computer-Aided Drug Revenue Market Forecast (2021-2025)
12.6 South America Computer-Aided Drug Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Computer-Aided Drug Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Computer-Aided Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Computer-Aided Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Computer-Aided Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Computer-Aided Drug Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Computer-Aided Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Market Positioning Of Vendors Corporate Information, Location and Competitors
Table 7. Market Positioning Of Vendors Computer-Aided Drug Major Business
Table 8. Market Positioning Of Vendors Computer-Aided Drug Total Revenue (USD Million) (2017-2018)
Table 9. Market Positioning Of Vendors SWOT Analysis
Table 10. Market Positioning Of Vendors Computer-Aided Drug Product and Solutions
Table 11. Market Positioning Of Vendors Computer-Aided Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. International Business Machines Corp. Corporate Information, Location and Competitors
Table 13. International Business Machines Corp. Computer-Aided Drug Major Business
Table 14. International Business Machines Corp. Computer-Aided Drug Total Revenue (USD Million) (2018-2019)
Table 15. International Business Machines Corp. SWOT Analysis
Table 16. International Business Machines Corp. Computer-Aided Drug Product and Solutions
Table 17. International Business Machines Corp. Computer-Aided Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Charles River Laboratories International Inc. Corporate Information, Location and Competitors
Table 19. Charles River Laboratories International Inc. Computer-Aided Drug Major Business
Table 20. Charles River Laboratories International Inc. Computer-Aided Drug Total Revenue (USD Million) (2017-2018)
Table 21. Charles River Laboratories International Inc. SWOT Analysis
Table 22. Charles River Laboratories International Inc. Computer-Aided Drug Product and Solutions
Table 23. Charles River Laboratories International Inc. Computer-Aided Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Aaranya Biosciences Pvt. Ltd. Corporate Information, Location and Competitors
Table 25. Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Major Business
Table 26. Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Total Revenue (USD Million) (2017-2018)
Table 27. Aaranya Biosciences Pvt. Ltd. SWOT Analysis
Table 28. Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Product and Solutions
Table 29. Aaranya Biosciences Pvt. Ltd. Computer-Aided Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Compchem Solutions Ltd. Corporate Information, Location and Competitors
Table 31. Compchem Solutions Ltd. Computer-Aided Drug Major Business
Table 32. Compchem Solutions Ltd. Computer-Aided Drug Total Revenue (USD Million) (2017-2018)
Table 33. Compchem Solutions Ltd. SWOT Analysis
Table 34. Compchem Solutions Ltd. Computer-Aided Drug Product and Solutions
Table 35. Compchem Solutions Ltd. Computer-Aided Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Albany Molecular Research Inc. Corporate Information, Location and Competitors
Table 37. Albany Molecular Research Inc. Computer-Aided Drug Major Business
Table 38. Albany Molecular Research Inc. Computer-Aided Drug Total Revenue (USD Million) (2017-2018)
Table 39. Albany Molecular Research Inc. SWOT Analysis
Table 40. Albany Molecular Research Inc. Computer-Aided Drug Product and Solutions
Table 41. Albany Molecular Research Inc. Computer-Aided Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Openeye Scientific Software Inc. Corporate Information, Location and Competitors
Table 43. Openeye Scientific Software Inc. Computer-Aided Drug Major Business
Table 44. Openeye Scientific Software Inc. Computer-Aided Drug Total Revenue (USD Million) (2017-2018)
Table 45. Openeye Scientific Software Inc. SWOT Analysis
Table 46. Openeye Scientific Software Inc. Computer-Aided Drug Product and Solutions
Table 47. Openeye Scientific Software Inc. Computer-Aided Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Chemical Computing Group ULC Corporate Information, Location and Competitors
Table 49. Chemical Computing Group ULC Computer-Aided Drug Major Business
Table 50. Chemical Computing Group ULC Computer-Aided Drug Total Revenue (USD Million) (2017-2018)
Table 51. Chemical Computing Group ULC SWOT Analysis
Table 52. Chemical Computing Group ULC Computer-Aided Drug Product and Solutions
Table 53. Chemical Computing Group ULC Computer-Aided Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Chembio Discovery Inc. Corporate Information, Location and Competitors
Table 55. Chembio Discovery Inc. Computer-Aided Drug Major Business
Table 56. Chembio Discovery Inc. Computer-Aided Drug Total Revenue (USD Million) (2017-2018)
Table 57. Chembio Discovery Inc. SWOT Analysis
Table 58. Chembio Discovery Inc. Computer-Aided Drug Product and Solutions
Table 59. Chembio Discovery Inc. Computer-Aided Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Kang Yusheng Information Technology Co. Ltd. Corporate Information, Location and Competitors
Table 61. Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Major Business
Table 62. Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Total Revenue (USD Million) (2017-2018)
Table 63. Kang Yusheng Information Technology Co. Ltd. SWOT Analysis
Table 64. Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Product and Solutions
Table 65. Kang Yusheng Information Technology Co. Ltd. Computer-Aided Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Pharmaron Beijing Co. Ltd. Corporate Information, Location and Competitors
Table 67. Pharmaron Beijing Co. Ltd. Computer-Aided Drug Major Business
Table 68. Pharmaron Beijing Co. Ltd. Computer-Aided Drug Total Revenue (USD Million) (2017-2018)
Table 69. Pharmaron Beijing Co. Ltd. SWOT Analysis
Table 70. Pharmaron Beijing Co. Ltd. Computer-Aided Drug Product and Solutions
Table 71. Pharmaron Beijing Co. Ltd. Computer-Aided Drug Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Global Computer-Aided Drug Revenue (Million USD) by Players (2015-2020)
Table 73. Global Computer-Aided Drug Revenue Share by Players (2015-2020)
Table 74. Global Computer-Aided Drug Revenue (Million USD) by Regions (2015-2020)
Table 75. Global Computer-Aided Drug Revenue Market Share by Regions (2015-2020)
Table 76. North America Computer-Aided Drug Revenue by Countries (2015-2020)
Table 77. North America Computer-Aided Drug Revenue Market Share by Countries (2015-2020)
Table 78. Europe Computer-Aided Drug Revenue (Million USD) by Countries (2015-2020)
Table 79. Asia-Pacific Computer-Aided Drug Revenue (Million USD) by Countries (2015-2020)
Table 80. South America Computer-Aided Drug Revenue by Countries (2015-2020)
Table 81. South America Computer-Aided Drug Revenue Market Share by Countries (2015-2020)
Table 82. Middle East and Africa Computer-Aided Drug Revenue (Million USD) by Countries (2015-2020)
Table 83. Middle East and Africa Computer-Aided Drug Revenue Market Share by Countries (2015-2020)
Table 84. Global Computer-Aided Drug Revenue (Million USD) by Type (2015-2020)
Table 85. Global Computer-Aided Drug Revenue Share by Type (2015-2020)
Table 86. Global Computer-Aided Drug Revenue Forecast by Type (2021-2025)
Table 87. Global Computer-Aided Drug Revenue by Application (2015-2020)
Table 88. Global Computer-Aided Drug Revenue Share by Application (2015-2020)
Table 89. Global Computer-Aided Drug Revenue Forecast by Application (2021-2025)
Table 90. Global Computer-Aided Drug Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Computer-Aided Drug Picture
Figure 2. Global Computer-Aided Drug Revenue Market Share by Type in 2019
Figure 3. Structure Based Drug Picture
Figure 4. Ligand Based Drug Picture
Figure 5. Computer-Aided Drug Revenue Market Share by Application in 2019
Figure 6. Oncological Disorders Picture
Figure 7. Neurological Disorders Picture
Figure 8. Other Picture
Figure 9. Global Computer-Aided Drug Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Computer-Aided Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Computer-Aided Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Computer-Aided Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Computer-Aided Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Computer-Aided Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Computer-Aided Drug Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Computer-Aided Drug Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Computer-Aided Drug Revenue Market Share in 2019
Figure 18. Global Top 10 Players Computer-Aided Drug Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Computer-Aided Drug Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Computer-Aided Drug Revenue Market Share by Regions (2015-2020)
Figure 22. Global Computer-Aided Drug Revenue Market Share by Regions in 2018
Figure 23. North America Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 24. Europe Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 26. South America Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 28. North America Computer-Aided Drug Revenue Market Share by Countries (2015-2020)
Figure 29. North America Computer-Aided Drug Revenue Market Share by Countries in 2019
Figure 30. USA Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 31. Canada Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 33. Europe Computer-Aided Drug Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Computer-Aided Drug Revenue Market Share by Countries in 2019
Figure 35. Germany Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 36. UK Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 37. France Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 38. Russia Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 39. Italy Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Computer-Aided Drug Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Computer-Aided Drug Revenue Market Share by Countries in 2019
Figure 42. China Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 43. Japan Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 44. Korea Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 45. India Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 47. South America Computer-Aided Drug Revenue Market Share by Countries (2015-2020)
Figure 48. South America Computer-Aided Drug Revenue Market Share by Countries in 2019
Figure 49. Brazil Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Computer-Aided Drug Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Computer-Aided Drug Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 54. UAE Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Computer-Aided Drug Revenue and Growth Rate (2015-2020)
Figure 57. Global Computer-Aided Drug Revenue Share by Type (2015-2020)
Figure 58. Global Computer-Aided Drug Revenue Share by Type in 2019
Figure 59. Global Computer-Aided Drug Market Share Forecast by Type (2021-2025)
Figure 60. Global Structure Based Drug Revenue Growth Rate (2015-2020)
Figure 61. Global Ligand Based Drug Revenue Growth Rate (2015-2020)
Figure 62. Global Computer-Aided Drug Revenue Share by Application (2015-2020)
Figure 63. Global Computer-Aided Drug Revenue Share by Application in 2019
Figure 64. Global Computer-Aided Drug Market Share Forecast by Application (2021-2025)
Figure 65. Global Oncological Disorders Revenue Growth Rate (2015-2020)
Figure 66. Global Neurological Disorders Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Computer-Aided Drug Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Computer-Aided Drug Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Computer-Aided Drug Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Computer-Aided Drug Revenue Market Forecast (2021-2025)
Figure 72. Europe Computer-Aided Drug Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Computer-Aided Drug Revenue Market Forecast (2021-2025)
Figure 74. South America Computer-Aided Drug Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Computer-Aided Drug Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel